Trademark: 79184643
Status Date
Friday, January 15, 2021
Registration Number
5029385
Registration Date
Tuesday, August 30, 2016
Filing Date
Friday, January 22, 2016
Published for Opposition
Tuesday, June 14, 2016
Cancellation Date
Friday, January 8, 2021
5 [ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; ] pharmaceutical products for the prevention and treatment of cancer and tumors [ ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma ]
In the statement, lines 4 through 21, " Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; " should be deleted. In the statement, " lines 22 through 24, " ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma " should be inserted.
May 23, 2021
Notification Of Possible Opposition - Processed By Ib
Oct 25, 2020
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Oct 24, 2020
Death Of International Registration
Nov 1, 2019
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Nov 1, 2019
Death Of International Registration
Jan 11, 2018
Invalidation Reviewed - No Action Required By Office
Dec 26, 2017
Partial Invalidation Of Reg Ext Protection Created
Apr 26, 2017
Limitation From The Ib Examined And Entered
Apr 26, 2017
Correction Under Section 7 ¿ Processed
Apr 26, 2017
Case Assigned To Post Registration Paralegal
Apr 7, 2017
Limitation Of Goods Received From Ib
Oct 21, 2016
Notification Processed By Ib
Oct 3, 2016
Final Disposition Notice Sent To Ib
Oct 3, 2016
Final Disposition Processed
Sep 29, 2016
Grant Of Protection Created, To Be Sent To Ib
Aug 30, 2016
Registered-Principal Register
Jul 28, 2016
Notification Of Possible Opposition - Processed By Ib
Jun 14, 2016
Published For Opposition
Jun 1, 2016
Notification Of Possible Opposition Sent To Ib
Jun 1, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 25, 2016
Notice Of Publication
May 4, 2016
Approved For Pub - Principal Register
May 2, 2016
Assigned To Examiner
Mar 25, 2016
Application Filing Receipt Mailed
Mar 21, 2016
New Application Office Supplied Data Entered In Tram
Mar 19, 2016
Limitation From Original Application Entered
Mar 17, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
